Procenten for seponering af forsøgslægemidler på grund af bivirkninger var 7, 2% for prasugrel og 6, 3% for clopidogrel.
The rate of study drug discontinuation due to adverse events was 7.2% for prasugrel and 6.3% for clopidogrel.